David Bernard Miklos
Stanford University
View profile
Collaboration graph - direct co-authors and who they connect you to
Stanford University
David Bernard Miklos (Stanford University) has co-authored with 905 scholars at 161 institutions, between 2008 and 2026. 627 of them within the last 4 years. Strongest collaborators, by shared papers: Matthew Joshua Frank, Sally Arai, Lori S. Muffly, Wen‐Kai Weng, Frederick Lundry Locke and Robert S. Negrin. 488 scholars on JRNLClub are one introduction away.
The strongest 12 of 905, by shared papers.
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
with Frederick Lundry Locke, Caron Alyce Jacobson and 6 more · 2017 · New England Journal of Medicine · 6,025 citations · DOI
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
with Frederick Lundry Locke, Caron Alyce Jacobson and 6 more · 2018 · The Lancet Oncology · 2,286 citations · DOI
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
with Frederick Lundry Locke, Caron Alyce Jacobson and 2 more · 2020 · New England Journal of Medicine · 1,863 citations · DOI
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
with Olalekan O. Oluwole and Armin Ghobadi · 2021 · New England Journal of Medicine · 1,608 citations · DOI
Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium
with Saurabh Dahiya, Sattva Swarup Neelapu and 1 more · 2020 · Journal of Clinical Oncology · 801 citations · DOI
h-index 122